Pamorelin LA 22.5mg Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Triptorelin (22.5mg)
Overview Pamorelin LA 22.5mg Injection
A 22.5mg subcutaneous injection of Pamorelin LA is indicated for managing prostate cancer. It also finds application in the treatment of endometriosis (characterized by excessive uterine endometrial growth, leading to pain, heavy or irregular menstruation) and central precocious puberty (premature onset of puberty). Administration is exclusively via subcutaneous injection by a healthcare professional. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's prescribed regimen is crucial; improper use or overdose may result in severe adverse effects. Therapeutic benefits may not be apparent immediately, potentially taking weeks or months; discontinue use only as directed by your doctor. Frequently reported side effects include hot flushes, weakness, diaphoresis, tiredness, backache, and impotence. Prolonged use may weaken bones, decreasing bone mineral density; calcium and vitamin D supplementation is advised. Amenorrhea (cessation of menstruation) for 7-12 weeks is possible; persistent bleeding requires medical attention. Prior to commencing treatment, disclose any history of alcohol consumption, smoking, or osteoporosis. Inform your healthcare provider of all medications you are currently taking, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Uses of Pamorelin LA 22.5mg Injection
Malignant prostate cells|Endometrial tissue disorder|Early-onset puberty
Major Benefits of Pamorelin LA 22.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Pamorelin LA 22.5mg Injection:
- Weakness
- Increased sweating
- Back pain
- Paresthesia (tingling or pricking sensation)
- Hot flashes
- Erectile dysfunction
How to use Pamorelin LA 22.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Pamorelin LA 22.5mg Injection works:
Pamorelin LA 22.5mg Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves suppressing testosterone levels in males. In females, it inhibits ovarian hormone synthesis, consequently reducing estrogen levels and impacting menstrual cycles.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pamorelin LA 22.5mg Injection may be unsafe; seek medical advice before combining them.
PregnancyUNSAFE
Administering Pamorelin LA 22.5mg Injection during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in animal and human studies has revealed considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Pamorelin LA 22.5mg Injection while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The injectable medication Pamorelin LA 22.5mg may induce adverse reactions that impair driving capabilities. These may include dizziness, fatigue, or visual disturbances like blurred vision, thus potentially affecting safe driving.
KidneyCAUTION
Patients with kidney impairment should use Pamorelin LA 22.5mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Pamorelin LA 22.5mg Injection. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Pamorelin LA 22.5mg Injection :
Should you forget a scheduled Pamorelin LA 22.5mg Injection, seek immediate medical advice.
Facts to Know About Pamorelin LA 22.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Category | GnRH agonists and antagonists |
3,018 People bought this recently